Abstract
Hematologic malignancies (HMs) are among the most prevalent and diverse types of cancer. Patients with HMs may experience a wide range of skin-related issues. These dermatological manifestations can be grouped into three main categories: Direct skin infiltration by malignant cells or their byproducts, cutaneous effects indirectly linked to the malignancy, and skin changes resulting from treatment. Such dermatological issues can significantly impact a patient’s quality of life. Managing these complex conditions requires a collaborative, multidisciplinary approach. Close coordination between dermatologists and hematologists is crucial for accurate diagnosis, personalized treatment planning, and ongoing monitoring.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call